Galen gets three year contract to chew on

Northern Ireland pharmaceutical company Galen Holdings said today it has won three-year exclusivity for its Ovcon product.

Northern Ireland pharmaceutical company Galen Holdings said today it has won three-year exclusivity for its Ovcon product.

Ovcon is marketed in the US by Galen's subsidiary Warner Chilcott. The new product is in the form of chewable tablets.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited